Avricore Health Inc. (AVCRF)
OTC PINK OTC PINK Primary Summary
AVCRF Chart
HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK
VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) today announced its successful integration of HealthTab™ the Company's cloud-connected, pharmacy-based platform for testing and health data management, with Patients Know Best (PKB), the UK's leading patient personal health record (PHR). The new partnership enables a seamless connection between real-time diagnostic results from pharmacy point-of-care testing and PKB's PHR platform, enhancing data accessibility for patients and healthcare providers alike.
Avricore Health Refocuses Strategy to Unlock Growth Potential
VANCOUVER, British Columbia, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSX-V: AVCR) ("Avricore" or the "Company"), a leader in pharmacy-based point-of-care testing solutions, today announces a strategic shift to increase its focus on the rapidly expanding UK healthcare market and begin concluding its Canadian pharmacy partnership with Shoppers Drug Mart. This shift in market development builds on the UCL Partners announcement of its rapid cholesterol initiative in community pharmacies in North East London.
Avricore Health Recognized in Deloitte's 2024 Technology Fast 50™ Companies to Watch
VANCOUVER, British Columbia, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSX-V: AVCR), a leader in pharmacy-based health technology solutions, proudly announces its placement in Deloitte Canada's 2024 Technology Fast 50™ Companies-to-Watch category, securing the 8th position with an impressive growth rate of 2738%. This award acknowledges Avricore's pioneering work in real-time data and health testing through its platform, HealthTab™, which empowers pharmacies to support patient health outcomes effectively.
Avricore Health Inc. Dividends
Avricore Health Inc. Earnings
| 28 May 2025 Date | | - Cons. EPS | - EPS |
| 27 Nov 2024 Date | | - Cons. EPS | - EPS |
| 29 Aug 2024 Date | | - Cons. EPS | 0 EPS |
| 28 Aug 2024 Date | | - Cons. EPS | - EPS |
| 20 Jun 2024 Date | | - Cons. EPS | 0 EPS |
| 28 May 2025 Date | | - Cons. EPS | - EPS |
| 27 Nov 2024 Date | | - Cons. EPS | - EPS |
| 29 Aug 2024 Date | | - Cons. EPS | 0 EPS |
| 28 Aug 2024 Date | | - Cons. EPS | - EPS |
| 20 Jun 2024 Date | | - Cons. EPS | 0 EPS |
Avricore Health Inc. (AVCRF) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Avricore Health Inc. ever had a stock split?
Avricore Health Inc. Profile
| Medical - Diagnostics & Research Industry | Healthcare Sector | Mr. Hector Bremner CEO | OTC PINK Exchange | 054521109 Cusip |
| CA Country | - Employees | - Last Dividend | 21 Nov 2016 Last Split | - IPO Date |
Overview
Avricore Health Inc. is a pioneering company in the health data and point-of-care technologies sector, based in Vancouver, Canada. Initially founded in 1996, the company embarked on its journey under the name Vanc Pharmaceuticals Inc. In October 2018, it underwent a significant rebranding, changing its name to Avricore Health Inc., marking a new era in its commitment to revolutionizing the way healthcare is delivered and managed. Avricore Health Inc. specializes in transforming pharmacies into community point-of-care diagnostic centers, making healthcare more accessible and efficient for the public.
Products and Services
- HealthTab - A cutting-edge turnkey point-of-care testing platform designed to empower pharmacies. This innovative solution transforms traditional pharmacies into fully functional community point-of-care diagnostic centers. By incorporating HealthTab, pharmacies are enabled to offer a wide range of diagnostic tests, facilitating immediate health insights for customers and enhancing the overall efficiency of healthcare delivery in the community.
Contact Information
